Use existing information
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Data collected from two clinical studies and one clinical trial conducted at Tohoku University Hospital in the past will be included. 1.Title of research: Clinical research using fetal electrocardiogram Research period: August 2009 - March 2019 Date of approval(most recent): April 11, 2014 (receipt number: 2014-1-23) Number of cases: 245 2.Title of the study: Registry study of fetal bio-signals using a new abdominal wall guidance method Research period: August 2015 - March 2019 Date of approval(most recent): December 12, 2018 (receipt number: 2018-2-242) Number of cases: 158 cases (only cases registered at Tohoku University Hospital) 3.Clinical trial title: Efficacy and safety evaluation study of Monitor 138 Clinical trial period: February, 2013 - January, 2015 Number of cases: 23
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency spectrum analysis is performed to confirm that the results extracted from the RAW data of biological signals by the maternal abdominal wall induction method are fetal-derived EEG signals. In addition, the fetal heart rate obtained at the same time is evaluated. In addition, the stage of sleep of the fetus is estimated from the fetal heart rate chart obtained at the same time, and the relationship with EEG is examined and evaluated. | — |
Countries
Japan
Contacts
Tohoku University Department of Maternal and Child Health Care Medical Science, Graduate School of Medicine